Skip to main content
Priority areas
- Targeting adenoviruses to tumors
- Oncolytic adenoviruses and other oncolytic viruses
- Gene therapy and oncolytic viruses in combination with other therapeutics
- Systemic delivery of gene therapy agents
- Arming oncolytic viruses
- Immunology of gene therapy
- Immunotherapy of cancer
- Using oncolytic viruses to stimulate the adoptive immune system
- Making T-cell therapies and checkpoint antibodies work in solid tumors
- Translating preclinical results into clinical trials
In particular, the following diseases are of interest
- Ovarian cancer
- Hormone refractory prostate cancer
- Metastatic breast cancer
- Lung cancer
- Metastatic colorectal cancer
- Pancreatic cancer
- Gastric cancer
- Kidney cancer
- Head and neck cancer